Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

<table>Kaplan Meier Analysis of overall survival before starting a new line of therapy for patients with metastatic breast cancer (a), metastatic colorectal cancer (b), and castration resistant prostate cancer (c). Patients were divided into those with Favorable and Unfavorable CTC. The cutoff value between favorable and unfavorable CTC was <svg height="11.25" id="M25" style="vertical-align:-1.29163pt" version="1.1" viewbox="0 0 15.175 11.25" width="15.175" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.25)">
<g transform="translate(72,-63)">
<text transform="matrix(1,0,0,-1,-71.95,64.34)">
<tspan style="font-size: 12.50px; " x="0" y="0">≥</tspan>
</text>
</g>
</g>
</svg>5 CTC/7.5 mL blood for breast and prostate cancer and <svg height="11.25" id="M26" style="vertical-align:-1.29163pt" version="1.1" viewbox="0 0 15.175 11.25" width="15.175" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.25)">
<g transform="translate(72,-63)">
<text transform="matrix(1,0,0,-1,-71.95,64.34)">
<tspan style="font-size: 12.50px; " x="0" y="0">≥</tspan>
</text>
</g>
</g>
</svg>3 CTC/7.5 mL blood for prostate cancer.</table>

Journal of Oncology

fig2

Figure 2

Figure 2: Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer 

Figure 2 | Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer 